(Q33347963)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Sirolimus: a single center experience in combination with calcineurin inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Kathy Nicholls

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

R Masterson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Leikis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Walker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

99S-104S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

Rapamycin: clinical results and future opportunities

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Sirolimus does not potentiate indices of chronic cyclosporin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin)

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900219-7

7 January 2021

10.1016/S0041-1345(03)00219-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12742476%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference